Published in Antimicrob Agents Chemother on January 01, 2006
Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev (2007) 15.82
Efflux pumps expression and its association with porin down-regulation and beta-lactamase production among Pseudomonas aeruginosa causing bloodstream infections in Brazil. BMC Microbiol (2010) 1.07
Metallo-beta-lactamases among imipenem-resistant Pseudomonas aeruginosa in a Brazilian university hospital. Clinics (Sao Paulo) (2010) 1.04
Prevalence of metallo-β-lactamase producing Pseudomonas aeruginosa and Acinetobacter species in intensive care areas in a tertiary care hospital. Indian J Crit Care Med (2010) 1.03
Detection of P. aeruginosa harboring bla CTX-M-2, bla GES-1 and bla GES-5, bla IMP-1 and bla SPM-1 causing infections in Brazilian tertiary-care hospital. BMC Infect Dis (2012) 0.97
Large dissemination of VIM-2-metallo-{beta}-lactamase-producing pseudomonas aeruginosa strains causing health care-associated community-onset infections. J Clin Microbiol (2009) 0.94
Molecular dynamic simulations of the metallo-beta-lactamase from Bacteroides fragilis in the presence and absence of a tight-binding inhibitor. J Mol Model (2008) 0.92
Detection of metallo-beta-lactamase producing Pseudomonas aeruginosa in intensive care units. Australas Med J (2013) 0.84
Evaluation of Zataria MultiFlora Boiss and Carum copticum antibacterial activity on IMP-type metallo-beta-lactamase-producing Pseudomonas aeruginosa. Ann Burns Fire Disasters (2013) 0.81
Novel bacteriophage therapy for controlling metallo-beta-lactamase producing Pseudomonas aeruginosa infection in catfish. BMC Vet Res (2013) 0.80
Epidemiology of VIM-1-imipenem resistant Pseudomonas aeruginosa in Iran: A systematic review and meta-analysis. J Res Med Sci (2014) 0.76
A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA (1994) 27.36
CDC definitions for nosocomial infections, 1988. Am J Infect Control (1988) 27.03
Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother (2000) 10.05
Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother (1994) 8.64
Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis (2002) 6.76
Convenient test for screening metallo-beta-lactamase-producing gram-negative bacteria by using thiol compounds. J Clin Microbiol (2000) 5.69
Multifocal outbreaks of metallo-beta-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum beta-lactams, including carbapenems. Antimicrob Agents Chemother (1996) 5.36
New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin Infect Dis (2001) 4.17
Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol (2001) 3.49
Molecular characterization of a beta-lactamase gene, blaGIM-1, encoding a new subclass of metallo-beta-lactamase. Antimicrob Agents Chemother (2004) 3.27
Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase. J Antimicrob Chemother (2003) 2.59
IMPs, VIMs and SPMs: the diversity of metallo-beta-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in a Brazilian hospital. Clin Microbiol Infect (2005) 1.99
Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-beta-lactamase, in a tertiary care center in Cali, Colombia. J Clin Microbiol (2004) 1.77
Clinical and bacteriological characteristics of IMP-type metallo-beta-lactamase-producing Pseudomonas aeruginosa. Clin Infect Dis (2003) 1.70
Integron carrying a novel metallo-beta-lactamase gene, blaIMP-16, and a fused form of aminoglycoside-resistant gene aac(6')-30/aac(6')-Ib': report from the SENTRY Antimicrobial Surveillance Program. Antimicrob Agents Chemother (2004) 1.51
Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes. J Antimicrob Chemother (2001) 1.47
Bacteremia due to Acinetobacter species other than Acinetobacter baumannii. Infection (1995) 1.24
Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis (2004) 20.99
Antibiotic prevention of acute exacerbations of COPD. N Engl J Med (2012) 4.11
Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis (2003) 3.53
Managing SARS amidst uncertainty. N Engl J Med (2003) 2.87
Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase. J Antimicrob Chemother (2003) 2.59
Screening inpatients for MRSA--case closed. N Engl J Med (2013) 2.44
Screening for MRSA: a flawed hospital infection control intervention. Infect Control Hosp Epidemiol (2008) 2.27
Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities. Pediatr Infect Dis J (2003) 2.22
First report of KPC-2-producing Klebsiella pneumoniae strains in Brazil. Antimicrob Agents Chemother (2008) 1.93
Positive deviance: a new strategy for improving hand hygiene compliance. Infect Control Hosp Epidemiol (2010) 1.64
Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States. J Infect (2011) 1.61
Escherichia coli ST502 and Klebsiella pneumoniae ST11 sharing an IncW plasmid harbouring the bla(KPC-2) gene in an Intensive Care Unit patient. Int J Antimicrob Agents (2012) 1.61
Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study. J Clin Microbiol (2011) 1.54
Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals. Clin Infect Dis (2005) 1.54
Comparative analysis of the complete genome of KPC-2-producing Klebsiella pneumoniae Kp13 reveals remarkable genome plasticity and a wide repertoire of virulence and resistance mechanisms. BMC Genomics (2014) 1.48
Infections associated with religious rituals. Int J Infect Dis (2013) 1.44
Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa. J Infect (2005) 1.43
Patient-to-patient transmission of hepatitis C virus. Ann Intern Med (2005) 1.40
Decreasing mortality in severe sepsis and septic shock patients by implementing a sepsis bundle in a hospital setting. PLoS One (2011) 1.35
Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence. BMC Infect Dis (2006) 1.31
Septic shock--evaluating another failed treatment. N Engl J Med (2012) 1.30
Hospital-acquired Clostridium difficile-associated disease in the intensive care unit setting: epidemiology, clinical course and outcome. BMC Infect Dis (2007) 1.22
A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection. BMC Infect Dis (2013) 1.20
Look before you leap: active surveillance for multidrug-resistant organisms. Clin Infect Dis (2007) 1.17
Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting. Diagn Microbiol Infect Dis (2013) 1.17
Successful prevention of ventilator-associated pneumonia in an intensive care setting. Am J Infect Control (2009) 1.16
Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program. Int J Infect Dis (2004) 1.12
Predicting hospital rates of fluoroquinolone-resistant Pseudomonas aeruginosa from fluoroquinolone use in US hospitals and their surrounding communities. Clin Infect Dis (2004) 1.12
Temporal evolution of carbapenem-resistant Acinetobacter baumannii in Curitiba, southern Brazil. Am J Infect Control (2010) 1.11
Measuring rates of hand hygiene adherence in the intensive care setting: a comparative study of direct observation, product usage, and electronic counting devices. Infect Control Hosp Epidemiol (2010) 1.11
Endocarditis due to vancomycin-resistant enterococci: case report and review of the literature. Clin Infect Dis (2005) 1.11
Epidemiology of bloodstream infections in patients receiving long-term total parenteral nutrition. J Clin Gastroenterol (2007) 1.10
Performance of MALDI-ToF MS for species identification of Burkholderia cepacia complex clinical isolates. Diagn Microbiol Infect Dis (2013) 1.09
Use of ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients. JPEN J Parenter Enteral Nutr (2007) 1.08
Impact of a program to prevent central line-associated bloodstream infection in the zero tolerance era. Am J Infect Control (2010) 1.06
Time to blood culture positivity as a predictor of clinical outcome of Staphylococcus aureus bloodstream infection. J Clin Microbiol (2006) 1.06
Post-malaria neurological syndrome: a case report and review of the literature. J Travel Med (2009) 1.05
A controlled trial of universal gloving versus contact precautions for preventing the transmission of multidrug-resistant organisms. Am J Infect Control (2007) 1.02
A program for sustained improvement in preventing ventilator associated pneumonia in an intensive care setting. BMC Infect Dis (2012) 1.02
Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci. BMC Infect Dis (2006) 1.01
Pyrosequencing-based analysis reveals a novel capsular gene cluster in a KPC-producing Klebsiella pneumoniae clinical isolate identified in Brazil. BMC Microbiol (2012) 1.00
Intravenous polymyxin B for the treatment of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa. Int J Antimicrob Agents (2007) 1.00
Community-acquired methicillin-resistant Staphylococcus aureus (MRSA): new issues for infection control. Int J Antimicrob Agents (2007) 0.98
Team-based prevention of catheter-related infections. N Engl J Med (2006) 0.96
Positive deviance: a program for sustained improvement in hand hygiene compliance. Am J Infect Control (2011) 0.95
A multicenter study using positive deviance for improving hand hygiene compliance. Am J Infect Control (2013) 0.92
Comparison of severity of illness scoring systems for patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa. BMC Infect Dis (2006) 0.92
Imipenem-resistant Pseudomonas aeruginosa infection at a medical-surgical intensive care unit: risk factors and mortality. J Crit Care (2009) 0.91
Clinical and microbiological characterization of KPC-producing Klebsiella pneumoniae infections in Brazil. Braz J Infect Dis (2011) 0.90
Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use. Emerg Infect Dis (2005) 0.90
Nosocomial bloodstream infections in Brazilian pediatric patients: microbiology, epidemiology, and clinical features. PLoS One (2013) 0.88
Infection control: the case for horizontal rather than vertical interventional programs. Int J Infect Dis (2010) 0.88
Influence of state laws mandating reporting of healthcare-associated infections: the case of central line-associated bloodstream infections. Infect Control Hosp Epidemiol (2013) 0.88
Practices and an assessment of health care workers' perceptions of compliance with infection control knowledge of nosocomial infections. Am J Infect Control (2005) 0.87
Vancomycin susceptibility of oxacillin-resistant Staphylococcus aureus isolates causing nosocomial bloodstream infections. J Clin Microbiol (2002) 0.87
Trial of universal gloving with emollient-impregnated gloves to promote skin health and prevent the transmission of multidrug-resistant organisms in a surgical intensive care unit. Infect Control Hosp Epidemiol (2010) 0.87
Controlled trial measuring the effect of a feedback intervention on hand hygiene compliance in a step-down unit. Infect Control Hosp Epidemiol (2008) 0.86
Carbapenem-resistant Pseudomonas aeruginosa: clonal spread in southern Brazil and in the state of Goiás. Braz J Infect Dis (2011) 0.86
Surgeons do not listen: evaluation of compliance with antimicrobial stewardship program recommendations. Am Surg (2013) 0.85
Targeted decolonization to prevent ICU infections. N Engl J Med (2013) 0.84
Quinolone-resistant Escherichia coli. Braz J Infect Dis (2008) 0.84
Effect of contact precautions on wait time from emergency room disposition to inpatient admission. Infect Control Hosp Epidemiol (2011) 0.84
Beta-lactam resistance mechanisms in Pseudomonas aeruginosa strains causing bloodstream infections: comparative results between Brazilian and American isolates. Microb Drug Resist (2012) 0.83
The effect of limiting antimicrobial therapy duration on antimicrobial resistance in the critical care setting. Am J Infect Control (2008) 0.82
Are gym surfaces reservoirs for Staphylococcus aureus? A point prevalence survey. Am J Infect Control (2012) 0.81
Central venous catheter colonization by linezolid-resistant, vancomycin-susceptible Enterococcus faecalis. J Clin Microbiol (2006) 0.81
Preparing for 2009 H1N1 Influenza. N Engl J Med (2009) 0.81
Hand Hygiene: State-of-the-Art Review With Emphasis on New Technologies and Mechanisms of Surveillance. Curr Infect Dis Rep (2012) 0.81
Time to blood culture positivity as a predictor of clinical outcome in patients with Candida albicans bloodstream infection. BMC Infect Dis (2013) 0.80
Improving the diagnosis of meningitis due to enterovirus and herpes simplex virus I and II in a tertiary care hospital. BMC Infect Dis (2013) 0.80
Listening to SARS: lessons for infection control. Ann Intern Med (2003) 0.80
Comparison of the systemic inflammatory response syndrome between monomicrobial and polymicrobial Pseudomonas aeruginosa nosocomial bloodstream infections. BMC Infect Dis (2005) 0.80
Systemic inflammatory response syndrome in nosocomial bloodstream infections with Pseudomonas aeruginosa and Enterococcus Species: comparison of elderly and nonelderly patients. J Am Geriatr Soc (2006) 0.79
Positive Deviance: A New Tool for Infection Prevention and Patient Safety. Curr Infect Dis Rep (2013) 0.79
Detection of PER-2-producing Enterobacter cloacae in a Brazilian liver transplantation unit. Antimicrob Agents Chemother (2014) 0.79
Outcomes of patients with alcohol use disorders experiencing healthcare-associated infections. Alcohol Clin Exp Res (2011) 0.79
Central line-associated bloodstream infection surveillance outside the intensive care unit: a multicenter survey. Infect Control Hosp Epidemiol (2012) 0.78
Clonal spread of carbapenem-resistant Serratia marcescens isolates sharing an IncK plasmid containing blaKPC-2. Int J Antimicrob Agents (2013) 0.78
Lessons from severe acute respiratory syndrome (SARS): implications for infection control. Arch Med Res (2005) 0.78
Risk factors for surgical site infection in kidney transplant recipients. Infect Control Hosp Epidemiol (2008) 0.78
Surgical site infection surveillance for neurosurgical procedures: a comparison of passive surveillance by surgeons to active surveillance by infection control professionals. Am J Infect Control (2007) 0.78
Secular trends in the epidemiology of Clostridium difficile infection (CDI): relationship with alcohol gel and antimicrobial usage in a hospital. Int J Infect Dis (2013) 0.77
Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in the intensive care unit: a real challenge to physicians, scientific community, and society. Shock (2013) 0.77
Metallo-β-lactamase-production in meropenem-susceptible Pseudomonas aeruginosa isolates: risk for silent spread. Mem Inst Oswaldo Cruz (2012) 0.77
Preventing catheter-associated urinary tract infection in the zero-tolerance era. Am J Infect Control (2011) 0.77
Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff. Cochrane Database Syst Rev (2016) 0.76
Measuring hand hygiene compliance in a hematology-oncology unit: a comparative study of methodologies. Am J Infect Control (2013) 0.76
Prevalence and clinical outcomes of episodes of ventilator-associated pneumonia caused by SPM-1-producing and non-producing imipenem-resistant Pseudomonas aeruginosa. Rev Soc Bras Med Trop (2011) 0.76
Hand hygiene compliance in the critical care setting: a comparative study of 2 different alcohol handrub formulations. Am J Infect Control (2012) 0.76
Positive deviance: using a nurse call system to evaluate hand hygiene practices. Am J Infect Control (2012) 0.76
The rising tide: skin and soft tissue infections due to community-associated methicillin-resistant Staphylococcus aureus. South Med J (2009) 0.75
Catheter related bloodstream infection (CR-BSI) in ICU patients: making the decision to remove or not to remove the central venous catheter. PLoS One (2012) 0.75
Antibiotics for abdominal sepsis. N Engl J Med (2015) 0.75
DRESS Syndrome due to Nevirapine Treated with Methylprednisolone. Case Rep Med (2013) 0.75
Understanding Luminal Microorganisms and Their Potential Effectiveness in Treating Intestinal Inflammation. Inflamm Bowel Dis (2016) 0.75
Is Selective Digestive Decontamination Useful for Critically Ill Patients? Shock (2017) 0.75